(Q48240229)

9 February 2018

title

Reduced PBR/TSPO expression after minocycline treatment in a rat model of focal cerebral ischemia: a PET study using [(18)F]DPA-714. (English)

1 reference

9 February 2018

1 reference

1 reference

1

1 reference

9 February 2018

Bertrand Tavitian

5

1 reference

9 February 2018

author name string

Raphaël Boisgard

2

1 reference

9 February 2018

Michael Kassiou

3

1 reference

9 February 2018

Frédéric Dollé

4

1 reference

9 February 2018

publication date

1 February 2011

1 reference

9 February 2018

Molecular Imaging and Biology

published in

1 reference

9 February 2018

volume

13

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

10-15

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s11307-010-0324-y

exact match

0 references

cites work

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Inflammation and infection in clinical stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Effects of minocycline alone and in combination with mild hypothermia in embolic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

[11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

A template for spatial normalisation of MR images of the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Extension of the thrombolytic time window with minocycline in experimental stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Effect of minocycline in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Multiphasic roles for matrix metalloproteinases after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

The promise of minocycline in neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0324-Y

Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice

21 January 2018

1 reference

12 December 2020

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

1 reference

12 December 2020

Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats

1 reference

12 December 2020

Evaluation of the PBR/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia

1 reference

12 December 2020

10.1007/S11307-010-0324-Y

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

20383592

1 reference

9 February 2018